Stretch, shrink, and shatter the rhythms: The intrinsic circadian period in mania and depression

CNS and Neurological Disorders - Drug Targets

Volumn 14, Issue 8, 2015, Pages 963-969

  Martynhak, Bruno Jacson ^a   Pereira, Marcela ^a   de souza, Camila Pasquini ^b   Andreatini, Roberto ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Antidepressants; Bipolar disorder; Depression; Endogenous circadian period; Mania; Mood stabilizers

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DESIPRAMINE; FLUOXETINE; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE 5; IMIPRAMINE; LITHIUM; METHAMPHETAMINE; MOCLOBEMIDE; PROTEIN KINASE B; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID; ANTIDEPRESSANT AGENT; TRANQUILIZER;

ANXIETY; ARTICLE; BIOLOGICAL RHYTHM; CIRCADIAN RHYTHM; DEPRESSION; FIBROBLAST; FORCED SWIM TEST; HUMAN; LOCOMOTION; MANIA; NONHUMAN; REM SLEEP; SLEEP DEPRIVATION; SUPRACHIASMATIC NUCLEUS; VENTRAL TEGMENTUM; ANIMAL; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER; HUMANS;

EID: 84945325094     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527314666150909115203     Document Type: Article

References (94)

1. Lemmer B. Discoveries of rhythms in human biological functions: a historical review. Chronobiol Int 2009; 26(6): 1019-68.
2. Monteleone P, Maj M. The circadian basis of mood disorders: recent developments and treatment implications. Eur Neuropsychopharmacol 2008; 18(10): 701-11.
3. Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RM. Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord 2008; 10(1 Pt 2): 144-52.
4. Kennedy SH, Tighe S, McVey G, Brown GM. Melatonin and cortisol "switches" during mania, depression, and euthymia in a drug-free bipolar patient. J Nerv Ment Dis 1989; 177(5): 300-3.
5. Ashkenazy T, Einat H, Kronfeld-Schor N. We are in the dark here: induction of depression- and anxiety-like behaviours in the diurnal fat sand rat, by short daylight or melatonin injections. Int J Neuropsychopharmacol 2009; 12(1): 83-93.
6. Ashkenazy T, Einat H, Kronfeld-Schor N. Effects of bright light treatment on depression- and anxiety-like behaviors of diurnal rodents maintained on a short daylight schedule. Behav Brain Res 2009; 201(2): 343-6.
7. Ashkenazy-Frolinger T, Kronfeld-Schor N, Juetten J, Einat H. It is darkness and not light: Depression-like behaviors of diurnal unstriped Nile grass rats maintained under a short photoperiod schedule. J Neurosci Methods 2010; 186(2): 165-70.
8. Prendergast BJ, Nelson RJ. Affective responses to changes in day length in Siberian hamsters (Phodopus sungorus). Psychoneuroendocrinology 2005; 30(5): 438-52.
9. Prendergast BJ, Kay LM. Affective and adrenocorticotrophic responses to photoperiod in Wistar rats. J Neuroendocrinol 2008; 20(2): 261-7.
10. Becker A, Bilkei-Gorzo A, Michel K, Zimmer A. Exposure of mice to long-light: a new animal model to study depression. Eur Neuropsychopharmacol 2010; 20(11): 802-12.
11. Gonzalez MM, Aston-Jones G. Light deprivation damages monoamine neurons and produces a depressive behavioral phenotype in rats. Proc Natl Acad Sci USA 2008; 105(12): 4898- 903.
12. Kubera M, Kenis G, Bosmans E, et al. Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol 2004; 4(2): 185-92.
13. Monje FJ, Cabatic M, Divisch I, et al. Constant darkness induces IL-6-dependent depression-like behavior through the NF-kappaB signaling pathway. J Neurosci 2011; 31(25): 9075-83.
14. Fonken LK, Finy MS, Walton JC, et al. Influence of light at night on murine anxiety- and depressive-like responses. Behav Brain Res 2009; 205(2): 349-54.
15. Martynhak BJ, Correia D, Morais LH, et al. Neonatal exposure to constant light prevents anhedonia-like behavior induced by constant light exposure in adulthood. Behav Brain Res 2011; 222(1): 10-4.
16. Possidente B, Lumia AR, McEldowney S, Rapp M. Fluoxetine shortens circadian period for wheel running activity in mice. Brain Res Bull 1992; 28(4): 629-31.
17. Wollnik F. Effects of chronic administration and withdrawal of antidepressant agents on circadian activity rhythms in rats. Pharmacol Biochem Behav 1992; 43(2): 549-61.
18. Nomura K, Castanon-Cervantes O, Davidson A, Fukuhara C. Selective serotonin reuptake inhibitors and raft inhibitors shorten the period of Period1-driven circadian bioluminescence rhythms in rat-1 fibroblasts. Life Sci 2008; 82(23-24): 1169-74.
19. Refinetti R, Menaker M. Effects of imipramine on circadian rhythms in the golden hamster. Pharmacol Biochem Behav 1993; 45(1): 27-33.
20. Nagayama H. Chronic administration of imipramine and lithium changes the phase-angle relationship between the activity and core body temperature circadian rhythms in rats. Chronobiol Int 1996; 13(4): 251-9.
21. Angles-Pujolras M, Diez-Noguera A, Soria V, Urretavizcaya M, Menchon JM, Cambras T. Electroconvulsive shock alters the rat overt rhythms of motor activity and temperature without altering the circadian pacemaker. Behav Brain Res 2009; 196(1): 37-43.
22. Meerlo P, Pragt BJ, Daan S. Social stress induces high intensity sleep in rats. Neurosci Lett 1997; 225(1): 41-4.
23. Meerlo P, Sgoifo A, Turek FW. The effects of social defeat and other stressors on the expression of circadian rhythms. Stress 2002; 5(1): 15-22.
24. Griesauer I, Diao W, Ronovsky M, et al. Circadian abnormalities in a mouse model of high trait anxiety and depression. Ann Med 2014; 46(3):148-54.
25. Rosenwasser AM, Hayes MJ. Neonatal desipramine treatment alters free-running circadian drinking rhythms in rats. Psychopharmacology 1994; 115(1-2): 237-44.
26. Shiromani PJ, Overstreet D. Free-running period of circadian rhythms is shorter in rats with a genetically upregulated central cholinergic system. Biol Psychiatry 1994; 36(9): 622-6.
27. Possidente B, Lumia AR, McGinnis MY, Rapp M, McEldowney S. Effects of fluoxetine and olfactory bulbectomy on mouse circadian activity rhythms. Brain Res 1996; 713(1-2): 108-13.
28. Stewart KT, Rosenwasser AM, Hauser H, Volpicelli JR, Adler NT. Circadian rhythmicity and behavioral depression: I. Effects of stress. Physiol Behav 1990; 48(1): 149-55.
29. Tang X, Yang L, Sanford LD. Rat strain differences in freezing and sleep alterations associated with contextual fear. Sleep 2005; 28(10): 1235-44.
30. Suchecki D, Tiba PA, Machado RB. REM Sleep Rebound as an Adaptive Response to Stressful Situations. Front Neurol 2012; 3: 41.
31. Jones D, Gershon S, Sitaram N, Keshavan M. Sleep and depression. Psychopathology 1987; 20 Suppl 1: 20-31.
32. Gillin JC, Wyatt RJ, Fram D, Snyder F. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology 1978; 59(3): 267-72.
33. Mayers AG, Baldwin DS. Antidepressants and their effect on sleep. Hum Psychopharmacol 2005; 20(8): 533-59.
34. Benedetti F, Colombo C. Sleep deprivation in mood disorders. Neuropsychobiology 2011; 64(3): 141-51.
35. Lopez-Rodriguez F, Kim J, Poland RE. Total sleep deprivation decreases immobility in the forced-swim test. Neuropsychopharmacology 2004; 29(6): 1105-11.
36. Riemann D, Konig A, Hohagen F, et al. How to preserve the antidepressive effect of sleep deprivation: A comparison of sleep phase advance and sleep phase delay. Eur Arch Psychiatry Clin Neurosci 1999; 249(5): 231-7.
37. Benedetti F, Barbini B, Colombo C, Smeraldi E. Chronotherapeutics in a psychiatric ward. Sleep Med Rev 2007; 11(6): 509-22.
38. Echizenya M, Suda H, Takeshima M, Inomata Y, Shimizu T. Total sleep deprivation followed by sleep phase advance and bright light therapy in drug-resistant mood disorders. J Affect Disord 2013; 144(1-2): 28-33.
39. Wehr TA, Sack DA, Rosenthal NE. Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 1987; 144(2): 201-4.
40. Gessa GL, Pani L, Fadda P, Fratta W. Sleep deprivation in the rat: an animal model of mania. Eur Neuropsychopharmacol 1995; 5 Suppl: 89-93.
41. Colombo C, Benedetti F, Barbini B, Campori E, Smeraldi E. Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res 1999; 86(3): 267- 70.
42. Wirz-Justice A. Chronobiology and mood disorders. Dialogues Clin Neurosci 2003; 5(4): 315-25.
43. Gaspar-Barba E, Calati R, Cruz-Fuentes CS, et al. Depressive symptomatology is influenced by chronotypes. J Affect Disord 2009; 119(1-3): 100-6.
44. Kitamura S, Hida A, Watanabe M, et al. Evening preference is related to the incidence of depressive states independent of sleepwake conditions. Chronobiol Int 2010; 27(9-10): 1797-812.
45. Duffy JF, Rimmer DW, Czeisler CA. Association of intrinsic circadian period with morningness-eveningness, usual wake time, and circadian phase. Behav Neurosci 2001; 115(4): 895-9.
46. Kara NZ, Einat H. Rodent models for mania: practical approaches. Cell Tissue Res 2013; 354(1): 191-201.
47. Roybal K, Theobold D, Graham A, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA 2007; 104(15): 6406-11.
48. Kirshenbaum GS, Clapcote SJ, Duffy S, et al. Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+- ATPase alpha3 sodium pump. Proc Natl Acad Sci USA 2011; 108(44): 18144-9.
49. Debruyne JP, Noton E, Lambert CM, Maywood ES, Weaver DR, Reppert SM. A clock shock: mouse CLOCK is not required for circadian oscillator function. Neuron 2006; 50(3): 465-77.
50. King DP, Zhao Y, Sangoram AM, et al. Positional cloning of the mouse circadian clock gene. Cell 1997; 89(4): 641-53.
51. Vitaterna MH, King DP, Chang AM, et al. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 1994; 264(5159): 719-25.
52. Mukherjee S, Coque L, Cao JL, et al. Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. Biol Psychiatry 2010; 68(6): 503-11.
53. Iwahana E, Akiyama M, Miyakawa K, et al. Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei. Eur J Neurosci 2004; 19(8): 2281-7.
54. Pereira M, Martynhak BJ, Baretta IP, Correia D, Siba IP, Andreatini R. Antimanic-like effect of tamoxifen is not reproduced by acute or chronic administration of medroxyprogesterone or clomiphene. Neurosci Lett 2011; 500(2): 95-8.
55. Barbosa FJ, Hesse B, de Almeida RB, Baretta IP, Boerngen- Lacerda R, Andreatini R. Magnesium sulfate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania. Pharmacol Rep 2011; 63(1): 64-70.
56. Sabioni P, Baretta IP, Ninomiya EM, Gustafson L, Rodrigues AL, Andreatini R. The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32(8): 1927- 31.
57. Valvassori SS, Budni J, Varela RB, Quevedo J. Contributions of animal models to the study of mood disorders. Rev Bras Psiquiatr 2013; 35 Suppl 2: S121-31.
58. Valvassori SS, Bavaresco DV, Budni J, et al. Effects of tamoxifen on tricarboxylic acid cycle enzymes in the brain of rats submitted to an animal model of mania induced by amphetamine. Psychiatry Res 2014; 215(2): 483-7.
59. Tataroglu O, Davidson AJ, Benvenuto LJ, Menaker M. The methamphetamine-sensitive circadian oscillator (MASCO) in mice. J Biol Rhythms 2006; 21(3): 185-94.
60. Mohawk JA, Miranda-Anaya M, Tataroglu O, Menaker M. Lithium and genetic inhibition of GSK3beta enhance the effect of methamphetamine on circadian rhythms in the mouse. Behav Pharmacol 2009; 20(2): 174-83.
61. Ozawa H, Miyauchi T. Potentiating effect of lithium chloride on methamphetamine-induced stereotypy in mice. Eur J Pharmacol 1977; 41(2): 213-6.
62. Miyauchi T, Kikuchi K, Satoh S. Further studies on the potentiating effect of lithium chloride on methamphetamineinduced stereotypy in mice. Jpn J Pharmacol 1981; 31(1): 61-8.
63. Youdim MB, Arraf Z. Prevention of MPTP (N-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax. Neuropharmacology 2004; 46(8): 1130-40.
64. Frey BN, Valvassori SS, Reus GZ, et al. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 2006; 31(5): 326- 32.
65. Cryan JF, Hoyer D, Markou A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol Psychiatry 2003; 54(1): 49-58.
66. Enman NM, Unterwald EM. Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse. Behav Brain Res 2012; 231(1): 217-25.
67. Prickaerts J, Moechars D, Cryns K, et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 2006; 26(35): 9022-9.
68. Beaulieu JM, Gainetdinov RR, Caron MG. Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 2009; 49: 327-47.
69. Lavoie J, Hebert M, Beaulieu JM. Glycogen synthase kinase-3beta haploinsufficiency lengthens the circadian locomotor activity period in mice. Behav Brain Res 2013; 253: 262-5.
70. O'Brien WT, Harper AD, Jove F, et al. Glycogen synthase kinase- 3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 2004; 24(30): 6791-8.
71. Martinek S, Inonog S, Manoukian AS, Young MW. A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock. Cell 2001; 105(6): 769-79.
72. Dokucu ME, Yu L, Taghert PH. Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila. Neuropsychopharmacology 2005; 30(12): 2216-24.
73. Li J, Lu WQ, Beesley S, Loudon AS, Meng QJ. Lithium impacts on the amplitude and period of the molecular circadian clockwork. PLoS One 2012; 7(3): e33292.
74. Hirota T, Lewis WG, Liu AC, Lee JW, Schultz PG, Kay SA. A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta. Proc Natl Acad Sci USA 2008; 105(52): 20746-51.
75. Paul JR, Johnson RL, Jope RS, Gamble KL. Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3. Neuroscience 2012; 226: 1-9.
76. Rietveld WJ, van Schravendijk K. Food intake and antiepileptic drugs: evidence for a role of GABA in circadian time keeping. Prog Clin Biol Res 1987; 227B: 507-11.
77. Chansard M, Molyneux P, Nomura K, Harrington ME, Fukuhara C. c-Jun N-terminal kinase inhibitor SP600125 modulates the period of mammalian circadian rhythms. Neuroscience 2007; 145(3): 812- 23.
78. Klemfuss H, Kripke DF. Antimanic drugs stabilize hamster circadian rhythms. Psychiatry Res 1995; 57(3): 215-22.
79. Ushijima K, Morikawa T, To H, Higuchi S, Ohdo S. Chronobiological disturbances with hyperthermia and hypercortisolism induced by chronic mild stress in rats. Behav Brain Res 2006; 173(2): 326-30.
80. Gorka Z, Moryl E, Papp M. Effect of chronic mild stress on circadian rhythms in the locomotor activity in rats. Pharmacol Biochem Behav 1996; 54(1): 229-34.
81. Kant GJ, Bauman RA, Pastel RH, Myatt CA, Closser-Gomez E, D'Angelo CP. Effects of controllable vs uncontrollable stress on circadian temperature rhythms. Physiol Behav 1991; 49(3): 625-30.
82. Honma KI, Hiroshige T. Endogenous ultradian rhythms in rats exposed to prolonged continuous light. Am J Physiol 1978; 235(5): R250-6.
83. Cambras T, Canal MM, Torres A, Vilaplana J, Diez-Noguera A. Manifestation of circadian rhythm under constant light depends on lighting conditions during lactation. Am J Physiol 1997; 272(4 Pt 2): R1039-46.
84. Cambras T, Vilaplana J, Torres A, et al. Constant bright light (LL) during lactation in rats prevents arrhythmicity due to LL. Physiol Behav 1998; 63(5): 875-82.
85. Fogg PC, O'Neill JS, Dobrzycki T, et al. Class IIa histone deacetylases are conserved regulators of circadian function. J Biol Chem 2014; 289(49): 34341-8.
86. Sun H, Kennedy PJ, Nestler EJ. Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology 2013; 38(1): 124-37.
87. Stetson MH, Watson-Whitmyre M. Nucleus suprachiasmaticus: the biological clock in the hamster? Science 1976; 191(4223): 197-9.
88. Tataroglu O, Aksoy A, Yilmaz A, Canbeyli R. Effect of lesioning the suprachiasmatic nuclei on behavioral despair in rats. Brain Res 2004; 1001(1-2): 118-24.
89. Flaisher-Grinberg S, Einat H. A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior. J Pharmacol Toxicol Methods 2009; 59(3): 141-5.
90. Zheng B, Larkin DW, Albrecht U, et al. The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 1999; 400(6740): 169-73.
91. Hampp G, Ripperger JA, Houben T, et al. Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol 2008; 18(9): 678-83.
92. LeGates TA, Altimus CM, Wang H, et al. Aberrant light directly impairs mood and learning through melanopsin-expressing neurons. Nature 2012; 491(7425): 594-8.
93. LeGates TA, Fernandez DC, Hattar S. Light as a central modulator of circadian rhythms, sleep and affect. Nat Rev Neurosci 2014; 15(7): 443-54.
94. de la Iglesia HO, Cambras T, Schwartz WJ, Diez-Noguera A. Forced desynchronization of dual circadian oscillators within the rat suprachiasmatic nucleus. Curr Biol 2004; 14(9): 796-800.